MedTrace Logo

A 24 Month Observational Study of Infants 3-24 Months, Who Suffer an Acute Episode of Respiratory Infection and Wheezing Illness

NCT03741322 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2020-11-25

No results posted yet for this study

Summary

This study will identify infants between the age of 3 and 24 months of age who are experiencing one of their first acute respiratory infections with confirmed wheezing. Infants who are also confirmed to be wheezing and whose caregiver signs consent will be enrolled from a primary care clinic, emergency room or hospital.

Conditions

  • Respiratory Tract Infections
  • Wheezing

Sponsors & Collaborators

Principal Investigators

  • Jason Lang, MD, MPH · Duke University

Eligibility

Min Age
3 Months
Max Age
24 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-12
Primary Completion
2020-06-16
Completion
2020-06-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03741322 on ClinicalTrials.gov